Valneva SE ADS (VALN)
NGS · ADR · CUSIP 92025Y103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VALN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
92025Y103
Market Cap
Large Cap
IPO
5/6/2021 · $26.41/share
ADR Ratio
2:1
Business: Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.

Company Contact

CEO
Thomas Lingelbach
CFO
Peter Bühler
Investor Relations
investors@valneva.com
SEC EDGAR Filings
View filings »